{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:30:52Z","timestamp":1715214652836},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,8]]},"DOI":"10.7759\/cureus.59878","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T12:01:15Z","timestamp":1715169675000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Study of the Effectiveness and Safety of Topical Calcipotriol and Topical Methotrexate in Chronic Plaque Psoriasis"],"prefix":"10.7759","author":[{"given":"Kamal","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhat","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Dermatology and sexually transmitted diseases, 6th edition (page 51)","author":"Khanna N","year":"2019","unstructured":"Khanna N. Dermatology and sexually transmitted diseases, 6th edition (page 51). Elsevier Health Sciences, 2019."},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon A","year":"2019","unstructured":"Rendon A, Schakel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019, 20:1475.","journal-title":"Int J Mol Sci"},{"key":"ref3","article-title":"Dermatology and sexually transmitted diseases, 6th edition (page 63)","author":"Khanna N","year":"2019","unstructured":"Khanna N. Dermatology and sexually transmitted diseases, 6th edition (page 63). Elsevier Health Sciences, 2019."},{"key":"ref4","article-title":"Dermatological pharmacology","author":"Sewell S","unstructured":"Sewell S, Burkhant N, Morrell D. Dermatological pharmacology. oodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e. Brunton L, Hilal-Dandan R, Knollmann B (ed): McGraw-Hill Education, New York, USA; 1277."},{"key":"ref5","article-title":"Essential of medical pharmacology, 8th edition","author":"Tripathy K","year":"2018","unstructured":"Tripathy K. Essential of medical pharmacology, 8th edition. Jaypee Brothers Medical Publishers, 2018."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102020-00008","article-title":"Calcipotriol ointment. A review of its use in the management of psoriasis","volume":"2","author":"Scott LJ","year":"2001","unstructured":"Scott LJ, Dunn CJ, Goa KL. Calcipotriol ointment. A review of its use in the management of psoriasis. Am J Clin Dermatol. 2001, 2:95-120. 10.2165\/00128071-200102020-00008","journal-title":"Am J Clin Dermatol"},{"key":"ref7","article-title":"Topical methotrexate in localized psoriasis","volume":"49","author":"Rath N","year":"2004","unstructured":"Rath N, Kar HK. Topical methotrexate in localized psoriasis. Indian J Dermatol. 2004, 49:128.","journal-title":"Indian J Dermatol"},{"key":"ref8","article-title":"Rang and Dale's pharmacology ninth edition","author":"Ritter J","year":"2018","unstructured":"Ritter J, Henderson G, Loke YK. Rang and Dale's pharmacology ninth edition. Elsevier Health Sciences, 2018."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1770170","article-title":"Topical methotrexate in dermatology: a review of the literature","volume":"33","author":"Aickara D","year":"2022","unstructured":"Aickara D, Bashyam AM, Pichardo RO, Feldman SR. Topical methotrexate in dermatology: a review of the literature. J Dermatolog Treat. 2022, 33:512-7. 10.1080\/09546634.2020.1770170","journal-title":"J Dermatolog Treat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.02911.x","article-title":"The treatment of psoriasis vulgaris: 1% topical methotrexate gel","volume":"45","author":"Eskicirak B","year":"2006","unstructured":"Eskicirak B, Zemheri E, Cerkezoglu A. The treatment of psoriasis vulgaris: 1% topical methotrexate gel. Int J Dermatol. 2006, 45:965-9. 10.1111\/j.1365-4632.2006.02911.x","journal-title":"Int J Dermatol"},{"key":"ref11","article-title":"Psoriasis in the tropics: an epidemiological survey","volume":"41","author":"Okhandiar RP","year":"1963","unstructured":"Okhandiar RP, Banerjee BN. Psoriasis in the tropics: an epidemiological survey. J Indian Med Assoc. 1963, 41:550-6.","journal-title":"J Indian Med Assoc"},{"key":"ref12","article-title":"Clinical profile of psoriasis in North India","volume":"61","author":"Bedi TR","year":"1995","unstructured":"Bedi TR. Clinical profile of psoriasis in North India. Indian J Dermatol Venereol Leprol. 1995, 61:202-5.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1997.tb02779.x","article-title":"Natural history of psoriasis: a study from the Indian subcontinent","volume":"24","author":"Kaur I","year":"1997","unstructured":"Kaur I, Handa S, Kumar B. Natural history of psoriasis: a study from the Indian subcontinent. J Dermatol. 1997, 24:230-4. 10.1111\/j.1346-8138.1997.tb02779.x","journal-title":"J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14074","article-title":"Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open-label randomized comparative pilot clinical study","volume":"45","author":"Alex P","year":"2020","unstructured":"Alex P, Williams S, Sutton L, Yesudas T, Sutton C, Thomas S, Centola M. Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open-label randomized comparative pilot clinical study. Clin Exp Dermatol. 2020, 45:318-22. 10.1111\/ced.14074","journal-title":"Clin Exp Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.286","article-title":"Add-on effect of PSORI-CM01 to topical calcipotriol for moderate psoriasis vulgaris: a multi-center, randomized, double-blind pilot study","volume":"11","author":"Parker S","year":"2021","unstructured":"Parker S, Zhang AL, Zhang CS, et al.. Add-on effect of PSORI-CM01 to topical calcipotriol for moderate psoriasis vulgaris: a multi-center, randomized, double-blind pilot study. Clin Transl Med. 2021, 11:e286. 10.1002\/ctm2.286","journal-title":"Clin Transl Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15285","article-title":"Clinical, dermoscopic, and histopathologic evaluation of topical methotrexate 1% hydrogel versus topical Calcipotriol 0.005% cream in the treatment of plaque psoriasis","volume":"21","author":"El Gayar MA","year":"2022","unstructured":"El Gayar MA, Atwa D, Girgis G, Marie L. Clinical, dermoscopic, and histopathologic evaluation of topical methotrexate 1% hydrogel versus topical Calcipotriol 0.005% cream in the treatment of plaque psoriasis. J Cosmet Dermatol. 2022, 21:5779-89. 10.1111\/jocd.15285","journal-title":"J Cosmet Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.09.018","article-title":"Nanoparticle-coupled topical methotrexate can normalize immune responses and induce tissue remodeling in psoriasis","volume":"140","author":"\u00d6zcan A","year":"2020","unstructured":"\u00d6zcan A, Sahin D, Impellizzieri D, et al.. Nanoparticle-coupled topical methotrexate can normalize immune responses and induce tissue remodeling in psoriasis. J Invest Dermatol. 2020, 140:1003-1014.e8. 10.1016\/j.jid.2019.09.018","journal-title":"J Invest Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S380218","article-title":"The anti-psoriatic efficacy and safety profile of topical and intralesional methotrexate: a literature review","volume":"15","author":"Chaiyabutr C","year":"2022","unstructured":"Chaiyabutr C, Punnakitikashem P, Silpa-Archa N, Wongpraprarut C, Chularojanamontri L. The anti-psoriatic efficacy and safety profile of topical and intralesional methotrexate: a literature review. Clin Cosmet Investig Dermatol. 2022, 15:2253-74. 10.2147\/CCID.S380218","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243030-00007","article-title":"Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris","volume":"43","author":"Murdoch D","year":"1992","unstructured":"Murdoch D, Clissold SP. Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs. 1992, 43:415-29. 10.2165\/00003495-199243030-00007","journal-title":"Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/247127-a-comparative-study-of-the-effectiveness-and-safety-of-topical-calcipotriol-and-topical-methotrexate-in-chronic-plaque-psoriasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T12:01:20Z","timestamp":1715169680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/247127-a-comparative-study-of-the-effectiveness-and-safety-of-topical-calcipotriol-and-topical-methotrexate-in-chronic-plaque-psoriasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.59878","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,8]]}}}